Health Insurance - Primary Care Investment Targets - Reimbursement and Reporting
Summary
HB494 requires certain health insurance carriers in Maryland — including insurers, nonprofit health service plans, and health maintenance organizations — to align reimbursement to health care providers with annual primary care investment targets established by the State. The bill applies to individual, group, and blanket health insurance policies and contracts delivered or issued for delivery in Maryland, and it directs covered entities to provide reimbursement in a manner that meets those targets beginning on or after February 1, 2026.
The bill also adds a new reporting requirement. When filing a premium rate or premium rate change with the Maryland Insurance Commissioner, a carrier must submit a description of its progress toward meeting the annual primary care investment targets. The measure ties primary care investment to the rate review process, giving the Commissioner additional information when evaluating filings and increasing transparency around how carriers are supporting primary care spending.
Impact
HB494 amends the Insurance Article by modifying § 11-603(c) and adding new § 15-717. It expands the regulatory framework for health insurance rate filings by requiring carriers to report on primary care investment progress and by establishing a substantive reimbursement obligation linked to state-set primary care investment targets. In practical terms, the bill affects insurers, nonprofit health plans, and HMOs operating in Maryland, as well as health care providers who may see increased primary care reimbursement pressure and more state oversight of carrier spending patterns.
Sentiment
The available legislative history suggests generally favorable sentiment toward the bill. It received a favorable committee report and passed the House on third reading by a substantial margin, 96 yeas to 35 nays. The vote pattern indicates broad support, though not unanimous, for using insurance regulation to promote primary care investment and to require carriers to account for that investment in premium filings.
Contention
The main point of contention appears to be the bill’s mandate that carriers meet state-established primary care investment targets through reimbursement practices, which may be viewed by opponents as a significant regulatory intervention in insurance pricing and claims payment. Another likely area of concern is the added reporting burden and the extent to which the Insurance Commissioner should use primary care investment progress in reviewing premium rate filings. Supporters appear to favor the bill as a way to strengthen primary care funding and accountability, while critics likely worry about cost impacts on premiums, administrative complexity, and insurer flexibility.